Skip to main content

Search

9 result(s) for 'author#Daniel R Feikin' within BMC

Page 1 of 1

Sort by: Relevance | Date

  1. Kenya introduced a pentavalent vaccine including the DTP, Haemophilus influenzae type b and hepatitis b virus antigens in Nov 2001 and strengthened immunization services. We estimated immunization coverage before...

    Authors: Moses Ndiritu, Karen D Cowgill, Amina Ismail, Salome Chiphatsi, Tatu Kamau, Gregory Fegan, Daniel R Feikin, Charles RJC Newton and J Anthony G Scott
    Citation: BMC Public Health 2006 6:132
  2. Although causing substantial morbidity, the burden of pneumococcal disease among older children and adults in Africa, particularly in rural settings, is not well-characterized. We evaluated pneumococcal bacter...

    Authors: Daniel R Feikin, Geoffrey Jagero, Barrack Aura, Godfrey M Bigogo, Joseph Oundo, Bernard W Beall, Angela Karani, Susan Morpeth, M Kariuki Njenga and Robert F Breiman
    Citation: BMC Infectious Diseases 2010 10:186
  3. In much of Africa, most individuals living with HIV do not know their status. Home-based counseling and testing (HBCT) leads to more HIV-infected people learning their HIV status. However, there is little data...

    Authors: Godfrey Bigogo, Manase Amolloh, Kayla F Laserson, Allan Audi, Barrack Aura, Warren Dalal, Marta Ackers, Deron Burton, Robert F Breiman and Daniel R Feikin
    Citation: BMC Infectious Diseases 2014 14:376
  4. In many GAVI-eligible countries, effectiveness of new vaccines will be evaluated by case-control methodology. To inform the design and assess selection bias of a future case-control study of rotavirus vaccine ...

    Authors: Sammy Khagayi, Jacqueline E Tate, Reuben Onkoba, Umesh Parashar, Frank Odhiambo, Deron Burton, Kayla Laserson and Daniel R Feikin
    Citation: BMC Infectious Diseases 2014 14:77
  5. Reducing acute respiratory infection burden in children in Africa remains a major priority and challenge. We analyzed data from population-based infectious disease surveillance for severe acute respiratory ill...

    Authors: Robert F Breiman, Leonard Cosmas, M Kariuki Njenga, John Williamson, Joshua A Mott, Mark A Katz, Dean D Erdman, Eileen Schneider, M Steven Oberste, John C Neatherlin, Henry Njuguna, Daniel M Ondari, Kennedy Odero, George O Okoth, Beatrice Olack, Newton Wamola…
    Citation: BMC Infectious Diseases 2015 15:95
  6. Pneumococci are spread by persons with nasopharyngeal colonization, a necessary precursor to invasive disease. Pneumococcal conjugate vaccines can prevent colonization with vaccine serotype strains. In 2011, K...

    Authors: Miwako Kobayashi, Laura M. Conklin, Godfrey Bigogo, Geofrey Jagero, Lee Hampton, Katherine E. Fleming-Dutra, Muthoni Junghae, Maria da Gloria Carvalho, Fabiana Pimenta, Bernard Beall, Thomas Taylor, Kayla F. Laserson, John Vulule, Chris Van Beneden, Lindsay Kim, Daniel R. Feikin…
    Citation: BMC Infectious Diseases 2017 17:25
  7. In order to better understand respiratory syncytial virus (RSV) epidemiology and burden in tropical Africa, optimal case definitions for detection of RSV cases need to be identified.

    Authors: Bryan O. Nyawanda, Joshua A. Mott, Henry N. Njuguna, Lilian Mayieka, Sammy Khagayi, Reuben Onkoba, Caroline Makokha, Nancy A. Otieno, Godfrey M. Bigogo, Mark A. Katz, Daniel R. Feikin and Jennifer R. Verani
    Citation: BMC Infectious Diseases 2016 16:218
  8. Streptococcus pneumoniae is a leading cause of pneumonia, meningitis and sepsis in developing countries, particularly among children and HIV-infected persons. Pneumococcal oropharyngeal (OP) or nasopharyngeal (NP...

    Authors: Laura M. Conklin, Godfrey Bigogo, Geofrey Jagero, Lee Hampton, Muthoni Junghae, Maria da Gloria Carvalho, Fabiana Pimenta, Bernard Beall, Thomas Taylor, Brian Plikaytis, Kayla F. Laserson, John Vulule, Chris Van Beneden, Cynthia G. Whitney, Robert F. Breiman and Daniel R. Feikin
    Citation: BMC Infectious Diseases 2016 16:18
  9. Rotavirus vaccine was introduced in Kenya immunization program in July 2014. Pre-vaccine disease burden estimates are important for assessing vaccine impact.

    Authors: Richard Omore, Sammy Khagayi, Billy Ogwel, Reuben Onkoba, John B. Ochieng, Jane Juma, Stephen Munga, Collins Tabu, Sergon Kibet, J. Pekka Nuorti, Frank Odhiambo, Jason M. Mwenda, Robert F. Breiman, Umesh D. Parashar and Jacqueline E. Tate
    Citation: BMC Infectious Diseases 2019 19:47